PDE7A Antikörper
Kurzübersicht für PDE7A Antikörper (ABIN2747196)
Target
Alle PDE7A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Affinity Purified
-
Immunogen
- Synthetic cyclic peptide common to all PDE7A variants
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.50-0.75 μg/μL
-
-
-
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
: "The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release." in: British journal of pharmacology, Vol. 157, Issue 4, pp. 633-44, (2009) (PubMed).
-
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
-
- PDE7A (phosphodiesterase 7A (PDE7A))
-
Andere Bezeichnung
- PDE7A
-
UniProt
- Q13946
-
Pathways
- cAMP Metabolic Process
Target
-